ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
1000 6 10 6 10 B-lower_bound
/ 10 11 10 11 I-lower_bound
mm3 11 14 11 14 I-lower_bound

AST 0 3 15 18 B-clinical_variable
and 4 7 19 22 O
ALT 8 11 23 26 B-clinical_variable
up 12 14 27 29 O
to 15 17 30 32 O
2.5 18 21 33 36 B-upper_bound
x 22 23 37 38 I-upper_bound
upper 24 29 39 44 I-upper_bound
limits 30 36 45 51 I-upper_bound
of 37 39 52 54 I-upper_bound
normal 40 46 55 61 I-upper_bound
( 47 48 62 63 I-upper_bound
ULN 48 51 63 66 I-upper_bound
) 51 52 66 67 I-upper_bound

Age 0 3 68 71 B-age
18 4 6 72 74 B-lower_bound
years 7 12 75 80 I-lower_bound
or 13 15 81 83 O
older 16 21 84 89 O
at 22 24 90 92 O
registration 25 37 93 105 O

Alkaline 0 8 106 114 B-clinical_variable
phosphatase 9 20 115 126 I-clinical_variable
up 21 23 127 129 O
to 24 26 130 132 O
2.5 27 30 133 136 B-upper_bound
x 31 32 137 138 I-upper_bound
ULN 33 36 139 142 I-upper_bound

Allergy 0 7 143 150 B-treatment
desensitization 8 23 151 166 I-treatment
injections 24 34 167 177 I-treatment

Bilirubin 0 9 178 187 B-clinical_variable
up 10 12 188 190 O
to 13 15 191 193 O
2.5 16 19 194 197 B-upper_bound
x 20 21 198 199 I-upper_bound
ULN 22 25 200 203 I-upper_bound

Body 0 4 204 208 B-clinical_variable
weight 5 11 209 215 I-clinical_variable
< 12 13 216 217 O
110 14 17 218 221 B-upper_bound
pounds 18 24 222 228 I-upper_bound

Corticosteroids 0 15 229 244 B-treatment
, 15 16 244 245 O
administered 17 29 246 258 O
transdermally 30 43 259 272 O
, 43 44 272 273 O
parenterally 45 57 274 286 O
or 58 60 287 289 O
orally 61 67 290 296 O

Creatinine 0 10 297 307 B-clinical_variable
up 11 13 308 310 O
to 14 16 311 313 O
1.5 17 20 314 317 B-upper_bound
x 21 22 318 319 I-upper_bound
ULN 23 26 320 323 I-upper_bound

ECOG 0 4 324 328 B-clinical_variable
performance 5 16 329 340 I-clinical_variable
status 17 23 341 347 I-clinical_variable
of 24 26 348 350 O
0 27 28 351 352 B-lower_bound
or 29 31 353 355 O
1 32 33 356 357 B-upper_bound

Each 0 4 358 362 O
brain 5 10 363 368 B-cancer
metastasis 11 21 369 379 I-cancer
must 22 26 380 384 O
have 27 31 385 389 O
been 32 36 390 394 O
completely 37 47 395 405 O
removed 48 55 406 413 O
by 56 58 414 416 O
surgery 59 66 417 424 B-treatment
or 67 69 425 427 O
each 70 74 428 432 O
unresected 75 85 433 443 O
brain 86 91 444 449 O
metastasis 92 102 450 460 O
must 103 107 461 465 O
have 108 112 466 470 O
been 113 117 471 475 O
treated 118 125 476 483 O
with 126 130 484 488 O
stereotactic 131 143 489 501 B-treatment
radiosurgery 144 156 502 514 I-treatment

Female 0 6 515 521 B-gender
participants 7 19 522 534 O
must 20 24 535 539 O
not 25 28 540 543 O
be 29 31 544 546 O
breastfeeding 32 45 547 560 O

Growth 0 6 561 567 O
factors 7 14 568 575 O
( 15 16 576 577 O
e.g. 16 20 577 581 O
Procrit 21 28 582 589 B-treatment
® 28 29 589 590 O
, 29 30 590 591 O
Aranesp 31 38 592 599 B-treatment
® 38 39 599 600 O
, 39 40 600 601 O
Neulasta 41 49 602 610 B-treatment
® 49 50 610 611 O
) 50 51 611 612 O

HIV 0 3 613 616 B-chronic_disease
positivity 4 14 617 627 O
or 15 17 628 630 O
evidence 18 26 631 639 O
of 27 29 640 642 O
active 30 36 643 649 O
Hepatitis 37 46 650 659 B-chronic_disease
C 47 48 660 661 I-chronic_disease
virus 49 54 662 667 I-chronic_disease

HgB 0 3 668 671 B-clinical_variable
- 3 4 671 672 I-clinical_variable
A1c 4 7 672 675 I-clinical_variable
≤ 8 9 676 677 O
7.5 10 13 678 681 B-upper_bound
% 13 14 681 682 I-upper_bound

Hgb 0 3 683 686 B-clinical_variable
> 4 5 687 688 O
9 6 7 689 690 B-lower_bound
g 8 9 691 692 I-lower_bound
/ 9 10 692 693 I-lower_bound
dL 10 12 693 695 I-lower_bound

Inhaled 0 7 696 703 B-treatment
steroids 8 16 704 712 I-treatment
( 17 18 713 714 O
e.g. 18 22 714 718 O
: 22 23 718 719 O
Advair 24 30 720 726 B-treatment
® 30 31 726 727 I-treatment
, 31 32 727 728 O
Flovent 33 40 729 736 B-treatment
® 40 41 736 737 I-treatment
, 41 42 737 738 O
Azmacort 43 51 739 747 B-treatment
® 51 52 747 748 I-treatment
) 52 53 748 749 O
are 54 57 750 753 O
not 58 61 754 757 O
permitted 62 71 758 767 O
. 71 72 767 768 O
Topical 73 80 769 776 B-treatment
corticosteroids 81 96 777 792 I-treatment
are 97 100 793 796 O
acceptable 101 111 797 807 O

Interleukins 0 12 808 820 B-treatment
( 13 14 821 822 O
e.g. 14 18 822 826 O
Proleukin 19 28 827 836 B-treatment
® 28 29 836 837 O
) 29 30 837 838 O

MEK 0 3 839 842 B-treatment
inhibitor 4 13 843 852 I-treatment

No 0 2 853 855 O
brain 3 8 856 861 B-cancer
metastasis 9 19 862 872 I-cancer
is 20 22 873 875 O
> 23 24 876 877 O
2 25 26 878 879 B-lower_bound
cm 27 29 880 882 I-lower_bound
in 30 32 883 885 I-lower_bound
diameter 33 41 886 894 I-lower_bound
at 42 44 895 897 O
the 45 48 898 901 O
time 49 53 902 906 O
of 54 56 907 909 O
registration 57 69 910 922 O

Participants 0 12 923 935 O
classified 13 23 936 946 O
according 24 33 947 956 O
to 34 36 957 959 O
the 37 40 960 963 O
New 41 44 964 967 O
York 45 49 968 972 O
Heart 50 55 973 978 O
Association 56 67 979 990 O
classification 68 82 991 1005 O
as 83 85 1006 1008 O
having 86 92 1009 1015 O
Class 93 98 1016 1021 B-chronic_disease
III 99 102 1022 1025 I-chronic_disease
or 103 105 1026 1028 I-chronic_disease
IV 106 108 1029 1031 I-chronic_disease
heart 109 114 1032 1037 I-chronic_disease
disease 115 122 1038 1045 I-chronic_disease

Participants 0 12 1046 1058 O
may 13 16 1059 1062 O
not 17 20 1063 1066 O
have 21 25 1067 1071 O
been 26 30 1072 1076 O
vaccinated 31 41 1077 1087 O
previously 42 52 1088 1098 O
with 53 57 1099 1103 O
any 58 61 1104 1107 O
of 62 64 1108 1110 O
the 65 68 1111 1114 O
synthetic 69 78 1115 1124 O
peptides 79 87 1125 1133 O
included 88 96 1134 1142 O
in 97 99 1143 1145 O
this 100 104 1146 1150 O
protocol 105 113 1151 1159 O
. 113 114 1159 1160 O
Participants 115 127 1161 1173 O
who 128 131 1174 1177 O
have 132 136 1178 1182 O
received 137 145 1183 1191 O
vaccinations 146 158 1192 1204 B-treatment
containing 159 169 1205 1215 O
agents 170 176 1216 1222 O
other 177 182 1223 1228 O
than 183 187 1229 1233 O
the 188 191 1234 1237 O
synthetic 192 201 1238 1247 O
peptides 202 210 1248 1256 O
included 211 219 1257 1265 O
in 220 222 1266 1268 O
this 223 227 1269 1273 O
protocol 228 236 1274 1282 O
and 237 240 1283 1286 O
have 241 245 1287 1291 O
recurred 246 254 1292 1300 O
during 255 261 1301 1307 O
or 262 264 1308 1310 O
after 265 270 1311 1316 O
administration 271 285 1317 1331 O
of 286 288 1332 1334 O
the 289 292 1335 1338 O
vaccine 293 300 1339 1346 O
will 301 305 1347 1351 O
be 306 308 1352 1354 O
eligible 309 317 1355 1363 O
to 318 320 1364 1366 O
enroll 321 327 1367 1373 O
12 328 330 1374 1376 B-upper_bound
weeks 331 336 1377 1382 I-upper_bound
following 337 346 1383 1392 O
their 347 352 1393 1398 O
last 353 357 1399 1403 O
vaccination 358 369 1404 1415 O

Participants 0 12 1416 1428 O
must 13 17 1429 1433 O
be 18 20 1434 1436 O
eligible 21 29 1437 1445 O
to 30 32 1446 1448 O
be 33 35 1449 1451 O
treated 36 43 1452 1459 O
with 44 48 1460 1464 O
BRAF 49 53 1465 1469 B-treatment
inhibitor 54 63 1470 1479 I-treatment
and 64 67 1480 1483 O
MEK 68 71 1484 1487 B-treatment
inhibitor 72 81 1488 1497 I-treatment
combination 82 93 1498 1509 O

Participants 0 12 1510 1522 O
must 13 17 1523 1527 O
have 18 22 1528 1532 O
at 23 25 1533 1535 O
least 26 31 1536 1541 O
two 32 35 1542 1545 B-lower_bound
intact 36 42 1546 1552 O
( 43 44 1553 1554 O
undissected 44 55 1554 1565 O
) 55 56 1565 1566 O
axillary 57 65 1567 1575 O
and/or 66 72 1576 1582 O
inguinal 73 81 1583 1591 O
lymph 82 87 1592 1597 O
node 88 92 1598 1602 O
basins 93 99 1603 1609 O

Participants 0 12 1610 1622 O
must 13 17 1623 1627 O
not 18 21 1628 1631 O
have 22 26 1632 1636 O
had 27 30 1637 1640 O
prior 31 36 1641 1646 O
autoimmune 37 47 1647 1657 O
disorders 48 57 1658 1667 O
requiring 58 67 1668 1677 O
cytotoxic 68 77 1678 1687 B-treatment
or 78 80 1688 1690 O
immunosuppressive 81 98 1691 1708 B-treatment
therapy 99 106 1709 1716 I-treatment
, 106 107 1716 1717 O
or 108 110 1718 1720 O
autoimmune 111 121 1721 1731 O
disorders 122 131 1732 1741 O
with 132 136 1742 1746 O
visceral 137 145 1747 1755 O
involvement 146 157 1756 1767 O

Participants 0 12 1768 1780 O
who 13 16 1781 1784 O
are 17 20 1785 1788 O
currently 21 30 1789 1798 O
receiving 31 40 1799 1808 O
a 41 42 1809 1810 O
checkpoint 43 53 1811 1821 B-treatment
molecule 54 62 1822 1830 I-treatment
blockade 63 71 1831 1839 I-treatment
therapy 72 79 1840 1847 I-treatment
, 79 80 1847 1848 O
or 81 83 1849 1851 O
who 84 87 1852 1855 O
have 88 92 1856 1860 O
received 93 101 1861 1869 O
this 102 106 1870 1874 O
therapy 107 114 1875 1882 O
within 115 121 1883 1889 O
3weeks 122 128 1890 1896 B-upper_bound
prior 129 134 1897 1902 I-upper_bound
to 135 137 1903 1905 O
registration 138 150 1906 1918 O

Participants 0 12 1919 1931 O
who 13 16 1932 1935 O
are 17 20 1936 1939 O
currently 21 30 1940 1949 O
receiving 31 40 1950 1959 O
nitrosoureas 41 53 1960 1972 B-treatment
or 54 56 1973 1975 O
who 57 60 1976 1979 O
have 61 65 1980 1984 O
received 66 74 1985 1993 O
this 75 79 1994 1998 O
therapy 80 87 1999 2006 O
6 88 89 2007 2008 B-upper_bound
weeks 90 95 2009 2014 I-upper_bound
prior 96 101 2015 2020 I-upper_bound
to 102 104 2021 2023 O
registration 105 117 2024 2036 O

Participants 0 12 2037 2049 O
who 13 16 2050 2053 O
have 17 21 2054 2058 O
metastatic 22 32 2059 2069 B-cancer
melanoma 33 41 2070 2078 I-cancer
available 42 51 2079 2088 O
for 52 55 2089 2092 O
biopsy 56 62 2093 2099 O
pretreatment 63 75 2100 2112 O
and 76 79 2113 2116 O
on 80 82 2117 2119 O
day 83 86 2120 2123 O
22 87 89 2124 2126 O
must 90 94 2127 2131 O
consent 95 102 2132 2139 O
to 103 105 2140 2142 O
having 106 112 2143 2149 O
those 113 118 2150 2155 O
biopsies 119 127 2156 2164 O
. 127 128 2164 2165 O
These 129 134 2166 2171 O
metastases 135 145 2172 2182 B-cancer
may 146 149 2183 2186 O
be 150 152 2187 2189 O
in 153 155 2190 2192 O
nodes 156 161 2193 2198 O
, 161 162 2198 2199 O
skin 163 167 2200 2204 O
, 167 168 2204 2205 O
soft 169 173 2206 2210 O
tissue 174 180 2211 2217 O
, 180 181 2217 2218 O
liver 182 187 2219 2224 O
, 187 188 2224 2225 O
or 189 191 2226 2228 O
other 192 197 2229 2234 O
sites 198 203 2235 2240 O
that 204 208 2241 2245 O
can 209 212 2246 2249 O
be 213 215 2250 2252 O
accessed 216 224 2253 2261 O
by 225 227 2262 2264 O
needle 228 234 2265 2271 B-treatment
biopsy 235 241 2272 2278 I-treatment
, 241 242 2278 2279 O
incisional 243 253 2280 2290 B-treatment
or 254 256 2291 2293 O
excisional 257 267 2294 2304 B-treatment
biopsy 268 274 2305 2311 I-treatment
, 274 275 2311 2312 O
with 276 280 2313 2317 O
or 281 283 2318 2320 O
without 284 291 2321 2328 O
image 292 297 2329 2334 O
guidance 298 306 2335 2343 O

Participants 0 12 2344 2356 O
who 13 16 2357 2360 O
have 17 21 2361 2365 O
received 22 30 2366 2374 O
the 31 34 2375 2378 O
following 35 44 2379 2388 O
medications 45 56 2389 2400 O
or 57 59 2401 2403 O
treatments 60 70 2404 2414 B-treatment
at 71 73 2415 2417 O
any 74 77 2418 2421 O
time 78 82 2422 2426 O
within 83 89 2427 2433 O
4 90 91 2434 2435 B-upper_bound
weeks 92 97 2436 2441 I-upper_bound
of 98 100 2442 2444 O
registration 101 113 2445 2457 O

Participants 0 12 2458 2470 O
with 13 17 2471 2475 O
a 18 19 2476 2477 O
known 20 25 2478 2483 O
history 26 33 2484 2491 O
of 34 36 2492 2494 O
glucose-6 37 46 2495 2504 B-chronic_disease
- 46 47 2504 2505 I-chronic_disease
phosphate 47 56 2505 2514 I-chronic_disease
dehydrogenase 57 70 2515 2528 I-chronic_disease
deficiency 71 81 2529 2539 I-chronic_disease

Participants 0 12 2540 2552 O
with 13 17 2553 2557 O
an 18 20 2558 2560 O
active 21 27 2561 2567 O
autoimmune 28 38 2568 2578 B-chronic_disease
disorder 39 47 2579 2587 I-chronic_disease
requiring 48 57 2588 2597 O
these 58 63 2598 2603 O
therapies 64 73 2604 2613 O
are 74 77 2614 2617 O
also 78 82 2618 2622 O
excluded 83 91 2623 2631 O

Participants 0 12 2632 2644 O
with 13 17 2645 2649 O
known 18 23 2650 2655 O
addiction 24 33 2656 2665 O
to 34 36 2666 2668 O
alcohol 37 44 2669 2676 O
or 45 47 2677 2679 O
drugs 48 53 2680 2685 O
who 54 57 2686 2689 O
are 58 61 2690 2693 O
actively 62 70 2694 2702 O
taking 71 77 2703 2709 O
those 78 83 2710 2715 O
agents 84 90 2716 2722 O
, 90 91 2722 2723 O
or 92 94 2724 2726 O
participants 95 107 2727 2739 O
with 108 112 2740 2744 O
recent 113 119 2745 2751 O
( 120 121 2752 2753 O
within 121 127 2753 2759 O
1 128 129 2760 2761 B-upper_bound
year 130 134 2762 2766 I-upper_bound
of 135 137 2767 2769 O
registration 138 150 2770 2782 O
) 150 151 2782 2783 O
or 152 154 2784 2786 O
ongoing 155 162 2787 2794 O
illicit 163 170 2795 2802 O
IV 171 173 2803 2805 O
drug 174 178 2806 2810 O
use 179 182 2811 2814 O

Participants 0 12 2815 2827 O
with 13 17 2828 2832 O
measurable 18 28 2833 2843 O
stage 29 34 2844 2849 B-cancer
IIIB 35 39 2850 2854 I-cancer
, 39 40 2854 2855 I-cancer
IIIC 41 45 2856 2860 I-cancer
, 45 46 2860 2861 I-cancer
or 47 49 2862 2864 I-cancer
IV 50 52 2865 2867 I-cancer
melanoma 53 61 2868 2876 I-cancer
that 62 66 2877 2881 O
have 67 71 2882 2886 O
clinical 72 80 2887 2895 O
or 81 83 2896 2898 O
radiological 84 96 2899 2911 O
evidence 97 105 2912 2920 O
of 106 108 2921 2923 O
disease 109 116 2924 2931 O

Participants 0 12 2932 2944 O
with 13 17 2945 2949 O
uncontrolled 18 30 2950 2962 B-chronic_disease
diabetes 31 39 2963 2971 I-chronic_disease
, 39 40 2971 2972 O
defined 41 48 2973 2980 O
as 49 51 2981 2983 O
having 52 58 2984 2990 O
a 59 60 2991 2992 O
HgB 61 64 2993 2996 B-clinical_variable
- 64 65 2996 2997 I-clinical_variable
A1c 65 68 2997 3000 I-clinical_variable
greater 69 76 3001 3008 O
than 77 81 3009 3013 O
7.5 82 85 3014 3017 B-lower_bound
% 85 86 3017 3018 I-lower_bound

Patients 0 8 3019 3027 O
known 9 14 3028 3033 O
to 15 17 3034 3036 O
have 18 22 3037 3041 O
Gilbert 23 30 3042 3049 B-chronic_disease
's 30 32 3049 3051 I-chronic_disease
disease 33 40 3052 3059 I-chronic_disease
may 41 44 3060 3063 O
be 45 47 3064 3066 O
eligible 48 56 3067 3075 O
with 57 61 3076 3080 O
AST 62 65 3081 3084 B-clinical_variable
and 66 69 3085 3088 O
ALT 70 73 3089 3092 B-clinical_variable
up 74 76 3093 3095 O
to 77 79 3096 3098 O
5 80 81 3099 3100 B-upper_bound
x 82 83 3101 3102 I-upper_bound
ULN 84 87 3103 3106 B-clinical_variable

Platelets 0 9 3107 3116 B-clinical_variable
> 10 11 3117 3118 O
100,000 12 19 3119 3126 B-lower_bound
/ 19 20 3126 3127 I-lower_bound
mm3 20 23 3127 3130 I-lower_bound

Pregnancy 0 9 3131 3140 B-pregnancy

Radiation 0 9 3141 3150 B-treatment
therapy 10 17 3151 3158 I-treatment
( 18 19 3159 3160 O
Stereotactic 19 31 3160 3172 B-treatment
radiotherapy 32 44 3173 3185 I-treatment
, 44 45 3185 3186 O
such 46 50 3187 3191 O
as 51 53 3192 3194 O
gamma 54 59 3195 3200 B-treatment
knife 60 65 3201 3206 I-treatment
, 65 66 3206 3207 O
can 67 70 3208 3211 O
be 71 73 3212 3214 O
used 74 78 3215 3219 O
≥ 79 80 3220 3221 O
1 81 82 3222 3223 B-lower_bound
week 83 87 3224 3228 I-lower_bound
and 88 91 3229 3232 O
≤ 92 93 3233 3234 O
6 94 95 3235 3236 B-upper_bound
months 96 102 3237 3243 I-upper_bound
prior 103 108 3244 3249 I-upper_bound
to 109 111 3250 3252 O
registration 112 124 3253 3265 O
) 124 125 3265 3266 O

Staging 0 7 3267 3274 O
of 8 10 3275 3277 O
cutaneous 11 20 3278 3287 B-cancer
melanoma 21 29 3288 3296 I-cancer
will 30 34 3297 3301 O
be 35 37 3302 3304 O
based 38 43 3305 3310 O
on 44 46 3311 3313 O
the 47 50 3314 3317 O
revised 51 58 3318 3325 O
AJCC 59 63 3326 3330 O
staging 64 71 3331 3338 O
system 72 78 3339 3345 O

Targeted 0 8 3346 3354 O
therapies 9 18 3355 3364 O
specific 19 27 3365 3373 O
for 28 31 3374 3377 O
mutated 32 39 3378 3385 O
BRAF 40 44 3386 3390 B-clinical_variable

The 0 3 3391 3394 O
most 4 8 3395 3399 O
recent 9 15 3400 3406 O
surgical 16 24 3407 3415 B-treatment
resections 25 35 3416 3426 I-treatment
or 36 38 3427 3429 O
gamma 39 44 3430 3435 B-treatment
- 44 45 3435 3436 I-treatment
knife 45 50 3436 3441 I-treatment
therapy 51 58 3442 3449 I-treatment
for 59 62 3450 3453 O
malignant 63 72 3454 3463 B-cancer
melanoma 73 81 3464 3472 I-cancer
must 82 86 3473 3477 O
have 87 91 3478 3482 O
been 92 96 3483 3487 O
completed 97 106 3488 3497 O
≥ 107 108 3498 3499 O
1 109 110 3500 3501 B-lower_bound
week 111 115 3502 3506 I-lower_bound
and 116 119 3507 3510 O
≤ 120 121 3511 3512 O
6 122 123 3513 3514 B-upper_bound
months 124 130 3515 3521 I-upper_bound
prior 131 136 3522 3527 I-upper_bound
to 137 139 3528 3530 O
registration 140 152 3531 3543 O

The 0 3 3544 3547 O
total 4 9 3548 3553 B-clinical_variable
number 10 16 3554 3560 I-clinical_variable
of 17 19 3561 3563 I-clinical_variable
brain 20 25 3564 3569 I-clinical_variable
metastases 26 36 3570 3580 I-clinical_variable
ever 37 41 3581 3585 O
≤ 42 43 3586 3587 O
3 44 45 3588 3589 B-upper_bound

There 0 5 3590 3595 O
has 6 9 3596 3599 O
been 10 14 3600 3604 O
no 15 17 3605 3607 O
evident 18 25 3608 3615 O
growth 26 32 3616 3622 O
of 33 35 3623 3625 O
any 36 39 3626 3629 O
brain 40 45 3630 3635 B-cancer
metastasis 46 56 3636 3646 I-cancer
since 57 62 3647 3652 O
the 63 66 3653 3656 O
most 67 71 3657 3661 O
recent 72 78 3662 3668 O
treatment 79 88 3669 3678 O

any 0 3 3679 3682 O
cancer 4 10 3683 3689 B-cancer
without 11 18 3690 3697 O
distant 19 26 3698 3705 O
metastasis 27 37 3706 3716 B-cancer
that 38 42 3717 3721 O
has 43 46 3722 3725 O
been 47 51 3726 3730 O
treated 52 59 3731 3738 O
successfully 60 72 3739 3751 O
, 72 73 3751 3752 O
without 74 81 3753 3760 O
evidence 82 90 3761 3769 O
of 91 93 3770 3772 O
recurrence 94 104 3773 3783 O
or 105 107 3784 3786 O
metastasis 108 118 3787 3797 O
for 119 122 3798 3801 O
over 123 127 3802 3806 O
3 128 129 3807 3808 B-lower_bound
years 130 135 3809 3814 I-lower_bound

basal 0 5 3815 3820 B-cancer
cell 6 10 3821 3825 I-cancer
cancer 11 17 3826 3832 I-cancer
of 18 20 3833 3835 I-cancer
the 21 24 3836 3839 I-cancer
skin 25 29 3840 3844 I-cancer
without 30 37 3845 3852 O
known 38 43 3853 3858 O
metastasis 44 54 3859 3869 B-cancer

carcinoma 0 9 3870 3879 B-cancer
in 10 12 3880 3882 I-cancer
situ 13 17 3883 3887 I-cancer
of 18 20 3888 3890 I-cancer
the 21 24 3891 3894 I-cancer
breast 25 31 3895 3901 I-cancer
( 32 33 3902 3903 I-cancer
DCIS 33 37 3903 3907 I-cancer
or 38 40 3908 3910 I-cancer
LCIS 41 45 3911 3915 I-cancer
) 45 46 3915 3916 I-cancer

carcinoma 0 9 3917 3926 B-cancer
in 10 12 3927 3929 I-cancer
situ 13 17 3930 3934 I-cancer
of 18 20 3935 3937 I-cancer
the 21 24 3938 3941 I-cancer
cervix 25 31 3942 3948 I-cancer

participants 0 12 3949 3961 O
may 13 16 3962 3965 O
have 17 21 3966 3970 O
had 22 25 3971 3974 O
cutaneous 26 35 3975 3984 B-cancer
, 35 36 3984 3985 O
uveal 37 42 3986 3991 B-cancer
, 42 43 3991 3992 O
mucosal 44 51 3993 4000 B-cancer
primary 52 59 4001 4008 I-cancer
melanoma 60 68 4009 4017 I-cancer
, 68 69 4017 4018 O
or 70 72 4019 4021 O
an 73 75 4022 4024 O
unknown 76 83 4025 4032 B-cancer
primary 84 91 4033 4040 I-cancer
melanoma 92 100 4041 4049 I-cancer

squamous 0 8 4050 4058 B-cancer
cell 9 13 4059 4063 I-cancer
cancer 14 20 4064 4070 I-cancer
of 21 23 4071 4073 I-cancer
the 24 27 4074 4077 I-cancer
skin 28 32 4078 4082 I-cancer
without 33 40 4083 4090 O
known 41 46 4091 4096 O
metastasis 47 57 4097 4107 B-cancer

